Literature DB >> 31095268

Insights Into Breast Cancer in the East vs the West: A Review.

Yoon-Sim Yap1, Yen-Shen Lu2, Kenji Tamura3, Jeong Eon Lee4, Eun Young Ko5, Yeon Hee Park6, A-Yong Cao7, Ching-Hung Lin2, Masakazu Toi8, Jiong Wu7, Soo-Chin Lee9,10.   

Abstract

IMPORTANCE: During the past few decades, the incidence of breast cancer (BC) has been increasing rapidly in East Asia, and BC is currently the most common cancer in several countries. The rising incidence is likely related to changing lifestyle and environmental factors in addition to the increase in early diagnosis with BC awareness and screening. The understanding and management of BC are generally based on research and data from the West. However, emerging differences in BC epidemiology and tumor and host biology in Asian populations may be clinically relevant. OBSERVATIONS: A higher proportion of premenopausal BCs occur in Asia, although this factor is possibly an age-cohort effect. Although the relative frequencies of different immunohistochemical subtypes of BC may be similar between the East and West, the higher prevalence of luminal B subtypes with more frequent mutations in TP53 may be confounded by disparities in early detection. In addition, Asian BCs appear to harbor a more immune-active microenvironment than BCs in the West. The spectra of germline mutations in BC predisposition genes and single-nucleotide polymorphisms contributing to BC risk vary with ethnicity as well. Differences in tolerability of certain cytotoxic and targeted agents used in BC treatment may be associated with pharmacogenomic factors, whereas the lower body mass of the average woman in East Asia may contribute to higher toxicities from drugs administered at fixed doses. Phenotypic characteristics, such as lower breast volume, may influence the type of surgery performed in East Asian women. On the other hand, increased breast density may affect the sensitivity of mammography in detecting BCs, limiting the benefits of screening mammography. CONCLUSIONS AND RELEVANCE: Breast cancer has become a major health problem in Asia. The inclusion of more women from Asia in clinical trials and epidemiologic and translational studies may help unravel the interethnic heterogeneity of BCs and elucidate the complex interplay between environmental and intrinsic factors in its pathogenesis. These insights may help to refine prevention, diagnosis, and management strategies for BC in the setting of ethnic diversity.

Entities:  

Year:  2019        PMID: 31095268     DOI: 10.1001/jamaoncol.2019.0620

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  37 in total

1.  Heterogeneous Associations Between Obesity and Reproductive-Related Factors and Specific Breast Cancer Subtypes Among Hong Kong Chinese Women.

Authors:  Priscilla Ming Yi Lee; Chi Hei Kwok; Wing Cheong Chan; Cherry Wu; Koon-Ho Tsang; Sze-Hong Law; Yiu-Cheong Yeung; Feng Wang; Xiaohong R Yang; Lap Ah Tse
Journal:  Horm Cancer       Date:  2020-06-03       Impact factor: 3.869

2.  Quantitative Mammographic Density Measurements and Molecular Subtypes in Chinese Women With Breast Cancer.

Authors:  Yuan Tian; Jennifer L Guida; Hela Koka; Er-Ni Li; Bin Zhu; Hyuna Sung; Ariane Chan; Han Zhang; Eric Tang; Changyuan Guo; Joseph Deng; Nan Hu; Ning Lu; Gretchen L Gierach; Jing Li; Xiaohong R Yang
Journal:  JNCI Cancer Spectr       Date:  2020-10-13

3.  Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.

Authors:  Yan Wang; Kai Chen; Yaping Yang; Luyuan Tan; Lili Chen; Liling Zhu; Fengxi Su; Xue Liu; Shunrong Li
Journal:  Ann Transl Med       Date:  2019-10

4.  Cost-effectiveness Analysis of Breast Cancer Screening Using Mammography in Singapore: A Modeling Study.

Authors:  Sarocha Chootipongchaivat; Xin Yi Wong; Kevin Ten Haaf; Mikael Hartman; Kelvin B Tan; Nicolien T van Ravesteyn; Hwee-Lin Wee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-02-02       Impact factor: 4.090

5.  Factors Influencing Mammographic Density in Asian Women: A Retrospective Cohort Study in the Northeast Region of Peninsular Malaysia.

Authors:  Tengku Muhammad Hanis; Wan Nor Arifin; Juhara Haron; Wan Faiziah Wan Abdul Rahman; Nur Intan Raihana Ruhaiyem; Rosni Abdullah; Kamarul Imran Musa
Journal:  Diagnostics (Basel)       Date:  2022-03-30

6.  Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer.

Authors:  Teresa Sullivan; Eswary Thirthagiri; Chan-Eng Chong; Stacey Stauffer; Susan Reid; Eileen Southon; Tiara Hassan; Aravind Ravichandran; Eldarina Wijaya; Joanna Lim; Nur Aishah Mohd Taib; Farhana Fadzli; Cheng Har Yip; Mikael Hartman; Jingmei Li; Rob M van Dam; Susan L North; Ranabir Das; Douglas F Easton; Kajal Biswas; Soo-Hwang Teo; Shyam K Sharan
Journal:  Hum Mutat       Date:  2020-12-31       Impact factor: 4.700

7.  Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer.

Authors:  Mi Jeong Kwon; Jeong Eon Lee; Joon Jeong; Sang Uk Woo; Jinil Han; Byeong-Il Kang; Jee-Eun Kim; Youngho Moon; Sae Byul Lee; Seonghoon Lee; Yoon-La Choi; Youngmi Kwon; Kyoung Song; Gyungyub Gong; Young Kee Shin
Journal:  Front Oncol       Date:  2019-07-24       Impact factor: 6.244

8.  Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study.

Authors:  Tone Hoel Lende; Marie Austdal; Tone Frost Bathen; Anne Elin Varhaugvik; Ivar Skaland; Einar Gudlaugsson; Nina G Egeland; Siri Lunde; Lars A Akslen; Kristin Jonsdottir; Emiel A M Janssen; Håvard Søiland; Jan P A Baak
Journal:  BMC Cancer       Date:  2019-12-04       Impact factor: 4.430

9.  Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL).

Authors:  Jiyun Lee; Seock-Ah Im; Gun Min Kim; Kyung Hae Jung; Seok Yun Kang; In Hae Park; Jee Hyun Kim; Hee Kyung Ahn; Yeon Hee Park
Journal:  Cancer Res Treat       Date:  2020-12-17       Impact factor: 4.679

10.  Breast Cancer in Megapolises of Kazakhstan: Epidemiological Assessment of Incidence and Mortality.

Authors:  Nurbek Igissinov; Assem Toguzbayeva; Botagoz Turdaliyeva; Gulnur Igissinova; Zarina Bilyalova; Gulnur Akpolatova; Murat Vansvanov; Dinar Tarzhanova; Akmaral Zhantureyeva; Marina Zhanaliyeva; Aigul Almabayeva; Alikhan Tautayev
Journal:  Iran J Public Health       Date:  2019-07       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.